Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DAPT(Dual Antiplatelet Therapy)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00977938
What this trial is testing

The Dual Antiplatelet Therapy Study (DAPT Study)

Who this might be right for
Coronary Artery Disease
Baim Institute for Clinical Research 25,682
Post-approval studies (Phase 4)Looking for participantsNCT04436978
What this trial is testing

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionAtrial Fibrillation+8 more
St. Antonius Hospital 2,000
Post-approval studies (Phase 4)Looking for participantsNCT06007222
What this trial is testing

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

Who this might be right for
Aortic StenosisTAVI(Transcatheter Aortic Valve Implantation)Aspirin+2 more
OCEAN-SHD Study Group 400
Very early researchStudy completedNCT03419325
What this trial is testing

A Genomic Approach for Clopidogrel in Caribbean Hispanics

Who this might be right for
Cardiovascular Disease (CVD)StrokeAcute Coronary Syndrome+3 more
University of Puerto Rico 150
Not applicableActive Not RecruitingNCT03971500
What this trial is testing

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

Who this might be right for
Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University 3,710
Post-approval studies (Phase 4)Study completedNCT01106534
What this trial is testing

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

Who this might be right for
Chronic Total Occlusion of Coronary ArteryVascular DiseaseMyocardial Ischemia+4 more
Abbott Medical Devices 870
Post-approval studies (Phase 4)UnknownNCT03775746
What this trial is testing

Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS

Who this might be right for
Acute Coronary Syndrome
East and North Hertfordshire NHS Trust 150
Not applicableStudy completedNCT07238764
What this trial is testing

OCT-based DAPT Cessation in HBR Patients

Who this might be right for
High Bleeding Risk PatientsDAPT(Dual Antiplatelet Therapy)Coronary Artery Disease+1 more
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 40
Not applicableLooking for participantsNCT07039149
What this trial is testing

Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

Who this might be right for
Major BleedingMajor Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Jordan Collaborating Cardiology Group 200
Not applicableLooking for participantsNCT07299994
What this trial is testing

Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease

Who this might be right for
StrokeThrombolysisDAPT(Dual Antiplatelet Therapy)+2 more
Sigmund Freud PrivatUniversitat 462
Not applicableLooking for participantsNCT05566301
What this trial is testing

Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Who this might be right for
Clopidogrel, Poor Metabolism ofCarotid Stenosis
IRCCS Policlinico S. Donato 1,140
Post-approval studies (Phase 4)UnknownNCT03112707
What this trial is testing

Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT

Who this might be right for
Coronary Artery DiseaseAcute Coronary Syndrome
Humanitas Hospital, Italy 1,023
Post-approval studies (Phase 4)Looking for participantsNCT06588595
What this trial is testing

The Switching Antiplatelet-9 (SWAP-9) Study

Who this might be right for
Coronary Arterial Disease (CAD)
University of Florida 90
Not applicableStudy completedNCT03848572
What this trial is testing

Repetitive Assessement of PRECISE-DAPT Score

Who this might be right for
Cardiovascular DiseasesInterventional Cardiology
University of Roma La Sapienza 500
Post-approval studies (Phase 4)Looking for participantsNCT07111559
What this trial is testing

Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

Who this might be right for
Lacunar StrokeStrokeIschemic Stroke
Nippon Medical School 500
Not applicableNot Yet RecruitingNCT07374718
What this trial is testing

Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk(HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 468
Large-scale testing (Phase 3)Not Yet RecruitingNCT07164859
What this trial is testing

Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

Who this might be right for
Coronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)Antiplatelet Therapy+1 more
Vincent ROULE 1,700
Large-scale testing (Phase 3)Looking for participantsNCT07195149
What this trial is testing

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

Who this might be right for
Chronic Coronary SyndromeStable Coronary Artery Disease CAD
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o. 1,703
Large-scale testing (Phase 3)UnknownNCT02798913
What this trial is testing

Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD

Who this might be right for
Peripheral Artery Disease
Federico II University 300
Not applicableNot Yet RecruitingNCT07354828
What this trial is testing

Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk (HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 3,500
Next Page